Case report: thermal helium in the treatment of coronavirus pneumonia caused by new coronavirus infection COVID-19 (SARS-CoV-2)
https://doi.org/10.20340/vmi-rvz.2021.1.COVID.1
Abstract
The novel SARS-CoV-2 coronavirus, which originated in December 2019 in Wuhan, China, has triggered an outbreak of a respiratory illness called COVID-19. Helium is a colorless inert gas, odorless and tasteless. Thermal helium-oxygen therapy is a new and innovative method that allows you to maintain the diffusion capacity of the lungs. The clinical case presented in this article shows that inhalation of a thermal gas mixture of helium and oxygen (t-He/O2) in the standard therapy of a patient with pneumonia caused by SARS-CoV-2 positively influenced the clinical picture of the disease, improves gas exchange, and promotes accelerating the elimination of the virus, rehabilitation and discharge of the patient.
About the Authors
S. V. Zhuravel’
Research Institute of Emergency Medicine named after N.V. Sklifosovsky
Moscow
P. V. Gavrilov
Research Institute of Emergency Medicine named after N.V. Sklifosovsky
Moscow
N. K. Kuznetsova
Research Institute of Emergency Medicine named after N.V. Sklifosovsky
Moscow
I. I. Utkina
Research Institute of Emergency Medicine named after N.V. Sklifosovsky
Moscow
M. A. Talyzin
Research Institute of Emergency Medicine named after N.V. Sklifosovsky
Russian Federation
Russian Federation
Moscow
V. E. Aleksandrova
Research Institute of Emergency Medicine named after N.V. Sklifosovsky
Moscow
References
1. 1 Kostimoe MP, SHmityso AD, Policuk VB, Hromova EA. Sovremennye predstavleniya o novoj koronaviruse i zabolevanii, vyzvannoj SARS-C0V-2. Infekcionnye bolezni: novosti, mneniya, obuchenie. 2020;9(2):33-42. https://doi.org/10.33029/2305-3496-2020-9-2-33-4
2. 2 Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. https://doi.org/10.1001/jama.2020.2648
3. 3 Barbara BB, Noemi GV, Jose LS, Jose Ignacio FV, Laura EP, Beatriz S, Julian GF, Jose M. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients. Exp Eye Res. 2020;200:108253. https://doi.org/10.1016/j.exer.2020.108253
4. 4 Petrikov SS, Zhuravel SV, Shogenova LV, Gavrilov PV, Utkina II, Varfolomeev SD, Ryabokon AM, Panin АА, Chuchalin AG. Thermal Helium-Oxygen Mixture as Part of a Treatment Protocol for Patients with COVID-19. Annals of the Russian Academy of Medical Sciences. 2020;75(5S):353–362. https://doi.org/10.15690/vramn1412
5. 5 Brygin PA, Zhuravel SV, Troitskiy DA, Utkina II. Predictors of extracorporeal membrane oxygenation efficacy in patients with acute respiratory failure. Transplantologiya. The Russian Journal of Transplantation. 2020;12(3):220-230. https://doi.org/10.23873/2074-0506-2020-12-3-220-2306
6. 6 Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020;55(5):105955. https://doi.org/10.1016/j.ijantimicag.2020.105955
7. 7 Kochhar RK. French astronomers in India during the 17th-19th centuries. Journal of the British Astronomical Association. 1991;101(2):95-100.
8. 8 Finkel'shtejn D.N. Inertnye gazy. Moscow: Nauka; 1979. 200 p.
9. 9 Varfolomeev SD, Panin AA, Bykov VI, Tsybenova SB, Shogenova LV, Chuchalin AG. Kinetic model of development of acute viral infection in the human body. Critical conditions, control mechanisms, "thermoheliox". Russ Chem Bull. 2020;69(6):1179-1184. https://doi: 10.1007/s11172-020-2886-4
Supplementary files
Review
For citations:
Zhuravel’ S.V., Gavrilov P.V., Kuznetsova N.K., Utkina I.I., Talyzin M.A., Aleksandrova V.E. Case report: thermal helium in the treatment of coronavirus pneumonia caused by new coronavirus infection COVID-19 (SARS-CoV-2). Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 2021;(1):5-10. (In Russ.) https://doi.org/10.20340/vmi-rvz.2021.1.COVID.1
Views:
598
Email this article 